| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 06/14/2011 | CA2451859C Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives as medicaments for the treatment of pain |
| 06/14/2011 | CA2430669C Synthesis of 3-amino-thalidomide and its enantiomers |
| 06/14/2011 | CA2428468C New 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them |
| 06/14/2011 | CA2426292C Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression |
| 06/14/2011 | CA2337205C Treatment of skin disorders |
| 06/14/2011 | CA2200540C Use of l-carnitine or derivatives thereof and antioxidants for the prevention and treatment of diseases elicited by oxidative stress to the nervous and cardiovascular system |
| 06/09/2011 | WO2011068303A2 Hyaluronic acid derivative effective against atopic dermatitis, and method for manufacturing same |
| 06/09/2011 | WO2011068171A1 Bicyclic nitrogen-containing saturated heterocyclic derivatives |
| 06/09/2011 | WO2011068147A1 Enhancement of melanin synthesis and activation of tyrosinase |
| 06/09/2011 | WO2011066656A1 Compositions comprising igf1 agonists and uses thereof |
| 06/09/2011 | WO2011066604A1 Acne treatment |
| 06/09/2011 | US20110136911 Treatment of sepsis and inhibition of mif by d-t4 |
| 06/09/2011 | US20110136900 Bruise amelioration composition and method of use |
| 06/09/2011 | US20110136881 Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents |
| 06/09/2011 | US20110136879 Compound |
| 06/09/2011 | US20110136877 2-phenyl phenoxyacetic acids useful for treating inflammatory disorders |
| 06/09/2011 | US20110136876 Altering Pharmacokinetics of Pirfenidone Therapy |
| 06/09/2011 | US20110136869 Compounds Which Selectively Modulate The CB2 Receptor |
| 06/09/2011 | US20110136861 Quinolone inhibitors of lipoprotein-associated phospholipase a2 |
| 06/09/2011 | US20110136860 Compounds |
| 06/09/2011 | US20110136859 Compounds |
| 06/09/2011 | US20110136857 Pyrrole[2,3-b]pyridine derivatives active as kinase inhibitors |
| 06/09/2011 | US20110136830 Chromenone derivatives |
| 06/09/2011 | US20110136828 Substituted n-oxide pyrazine derivatives |
| 06/09/2011 | US20110136816 Compounds that modulate intracellular calcium |
| 06/09/2011 | US20110136812 Solubilized topoisomerase poisons |
| 06/09/2011 | US20110136802 Ship1 modulators and methods related thereto |
| 06/09/2011 | US20110136801 Novel Compounds |
| 06/09/2011 | US20110136783 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists |
| 06/09/2011 | US20110136780 Dihydropyrrolonaphtyridinone compounds as inhibitors of jak |
| 06/09/2011 | US20110136778 Nitrogen-containing spirocyclic compounds and pharmaceutical uses thereof |
| 06/09/2011 | US20110136776 Copper(1)Chloride Complex of Nicotinic Acid and Pharmaceutical Compositions Containing the Same |
| 06/09/2011 | US20110136768 Imatinib mesylate for the treatment of nephrogenic systemic fibrosis |
| 06/09/2011 | US20110136765 Pyrrolo[2,3-D]Pyrimidine Compounds |
| 06/09/2011 | US20110136757 Hypersulfated disaccharide formulations |
| 06/09/2011 | US20110135767 Synergistic antioxidant combinations of herb extracts and methods relating thereto |
| 06/09/2011 | US20110135765 Synergistic antioxidant combinations of herb extracts and methods relating thereto |
| 06/09/2011 | US20110135756 Compositions and methods for protecting sensory hair cells |
| 06/09/2011 | US20110135747 Homeopathic therapeutic method |
| 06/09/2011 | US20110135742 Controlled release encapsulated anti-bacterial and anti-inflammatory nanoparticles |
| 06/09/2011 | US20110135726 Hydrogel composites and wound dressings |
| 06/09/2011 | US20110135714 Compositions for external application, containing adenosyl cobalamin for improvement of skin diseases |
| 06/09/2011 | US20110135707 Polyhydroxyalkanoates for in vivo applications |
| 06/09/2011 | US20110135652 Novel Use of Idbf |
| 06/09/2011 | US20110135632 Methods for the modulation of angiogenesis |
| 06/09/2011 | US20110135625 Controlled release enzymatic composition and methods of use |
| 06/09/2011 | US20110135621 Inhibiting bacterial infection and biofilm formation |
| 06/09/2011 | US20110135597 Uses of Mammalian Cytokine; Related Reagents |
| 06/09/2011 | US20110135584 Pharmaceutical/cosmetic, e.g., anti-acne compositions comprising at least one naphthoic acid compound, benzoyl peroxide and at least one film-forming agent |
| 06/09/2011 | US20110135573 Metalloproteinase 9 and metalloproteinase 2 binding proteins |
| 06/09/2011 | DE102009057267A1 Ointment, useful for treating Mortellaro's disease in cloven-hoofed animals, comprises a mixture of cereal hydrolyzate, acid whey and water, where the mixture is added with calcium chloride, magnesium chloride and iron saccharate |
| 06/08/2011 | EP2330212A1 Novel compound ceramidastin, process for production thereof, and use thereof |
| 06/08/2011 | EP2330193A1 Improved antibody molecule |
| 06/08/2011 | EP2330192A1 Polypeptides and polynucleotides from coagulase-negative staphylococci |
| 06/08/2011 | EP2330187A2 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic diseases |
| 06/08/2011 | EP2329849A1 Combination of alpha-2 adrenergic receptor agonist and non-steroidal anti-inflammatory agent for treating or preventing an inflammatory skin disorder |
| 06/08/2011 | EP2329842A2 Interleukin-1 inhibitors in the treatment of diseases |
| 06/08/2011 | EP2329828A1 Tetracyclines for the treatment of ischaemia |
| 06/08/2011 | EP2329826A1 Tetracyclines for the treatment of multiple sclerosis |
| 06/08/2011 | EP2329823A1 Method for improving absorbability of preparation, and preparation having improved absorbability |
| 06/08/2011 | EP2329723A1 Fruit and/or vegetable derived composition |
| 06/08/2011 | EP2329717A1 Disinfectant and/or bactericidal aqueous compositions |
| 06/08/2011 | EP2328886A1 Derivatives of triazines and uracils, their preparation and their application in human therapeutics |
| 06/08/2011 | EP2328875A2 Targeted nitroxide agents |
| 06/08/2011 | EP2328545A2 Use of glucosylglycerol |
| 06/08/2011 | EP1940383B1 Treatment and prevention of benign pigmented moles (naevi) using artemisinine and the derivatives thereof |
| 06/08/2011 | EP1538927B1 Fruit and/or vegetable derived composition |
| 06/08/2011 | EP1434579B1 Imidazole derivatives as antiinflammatory agents |
| 06/08/2011 | EP1427427B1 Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 06/08/2011 | CN1954873B Traditional Chinese medicine composition and its preparation method |
| 06/08/2011 | CN1943697B Dermatophytosis liquid |
| 06/08/2011 | CN102089283A Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group |
| 06/08/2011 | CN102089281A Novel indole derivative having carbamoyl group, ureide group and substituted oxy group |
| 06/08/2011 | CN102089277A Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same |
| 06/08/2011 | CN102088995A Use of angiogenin or angiogenin agonists for treating diseases and disorders |
| 06/08/2011 | CN102088978A Ameliorating or therapeutic agent for dyslipidemia |
| 06/08/2011 | CN102088967A Therapy regimen for treating acne related diseases |
| 06/08/2011 | CN102088957A Topical composition for the treatment of actinic keratosis |
| 06/08/2011 | CN102088956A Proguanil to treat skin/mucosal diseases |
| 06/08/2011 | CN102088947A Compositions based on polymer/hydrogen peroxide complexes and uses thereof |
| 06/08/2011 | CN102088946A Compositions for topical application comprising microencapsulated colorants |
| 06/08/2011 | CN102086451A Method for amplifying seed cells of skin tissue engineering |
| 06/08/2011 | CN102086212A Antifungal agents of 2,3,4,5-tetrahydro-4H-benzo[b]thiopyrano[4,3,c]pyrazole-2-formamide derivatives |
| 06/08/2011 | CN102086195A Dasatinib polymorphic substance as well as preparation method and medicinal composition thereof |
| 06/08/2011 | CN102085372A Application of Notch pathway inhibitor in treatment of tumors caused by activation of mTOR |
| 06/08/2011 | CN102085351A Anti-alopecia hair-growing composition for external use and preparation method thereof |
| 06/08/2011 | CN102085342A External cassia bark and monkshood powder for neonatal scleredema |
| 06/08/2011 | CN102085341A Degreasing and hair-growing preparation for preventing and treating seborrheic alopecia and preparation method thereof |
| 06/08/2011 | CN102085340A Aqua for treating chilblain |
| 06/08/2011 | CN102085333A Medicament for treating leucoderma |
| 06/08/2011 | CN102085319A Medicament for treating verruca plana and preparation method thereof |
| 06/08/2011 | CN102085308A Traditional Chinese medicine prescription for treating skin allergy |
| 06/08/2011 | CN102085306A Chinese medicinal rhagadia paste |
| 06/08/2011 | CN102085300A Traditional Chinese medicine composition for treating acne |
| 06/08/2011 | CN102085276A Formula of traditional Chinese medicine freckle-removing cream and preparation method thereof |
| 06/08/2011 | CN102085267A Traditional Chinese medicinal washing liquid for treating female vulvitis |
| 06/08/2011 | CN102085259A Traditional Chinese medicinal washing liquid for treating infantile eczema |
| 06/08/2011 | CN102085250A Goldthread root dispersible tablets |
| 06/08/2011 | CN102085246A Pure traditional Chinese medicine paint for treating acne |
| 06/08/2011 | CN102085245A Traditional Chinese medicine with functions of treating drug addiction, healing wounds and relieving cancer pain |